In functional assays, HMGB3 knockdown in ESCC cell lines led to a marked reduction in cell proliferation (CCK-8 assay), invasive capacity (Transwell assay), and colony-forming ability (clonogenic assay). Here, HMGB3 is linked to esophageal squamous cell carcinoma.